These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32334774)

  • 1. Comment on "Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Alzheimer's Patients".
    Naharci MI; Tasci I
    J Am Med Dir Assoc; 2020 May; 21(5):706-707. PubMed ID: 32334774
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' Response to Association between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
    Kim JH; Byun SJ; Shin JY
    J Am Med Dir Assoc; 2020 May; 21(5):707. PubMed ID: 32334775
    [No Abstract]   [Full Text] [Related]  

  • 3. Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
    Won DY; Byun SJ; Jeong JS; Shin JY
    J Am Med Dir Assoc; 2020 Aug; 21(8):1128-1133.e1. PubMed ID: 31926798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Tamimi I; Nicolau B; Eimar H; Arekunnath Madathil S; Kezouh A; Karp I; Tamimi F
    Osteoporos Int; 2018 Apr; 29(4):849-857. PubMed ID: 29264626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP
    CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Pisa syndrome and cholinesterase inhibitor use for elderly adults with Alzheimer's disease.
    Huvent-Grelle D; Boulanger E; Puisieux F
    J Am Geriatr Soc; 2014 Dec; 62(12):2450-3. PubMed ID: 25516048
    [No Abstract]   [Full Text] [Related]  

  • 7. Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease.
    Alonge O; Iqbal FM; Cifonelli E
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
    Bogardus ST
    J Psychiatry Neurosci; 2001 Nov; 26(5):425. PubMed ID: 11762210
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.
    VanDenBerg CM; Kazmi Y; Jann MW
    Drugs Aging; 2000 Feb; 16(2):123-38. PubMed ID: 10755328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer dementia].
    Hock C; Nitsch RM
    Praxis (Bern 1994); 2000 Mar; 89(13):529-40. PubMed ID: 10776055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
    Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients].
    Huvent-Grelle D; Roche J; Gaxatte C; Dewailly P; Puisieux F
    Presse Med; 2009 Jan; 38(1):150-3. PubMed ID: 18986791
    [No Abstract]   [Full Text] [Related]  

  • 15. Intra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors.
    Jones PM; Soderman RM
    Anaesthesia; 2007 Feb; 62(2):201. PubMed ID: 17223834
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease.
    Huvent-Grelle D; Roche J; Camus FE; Dewailly P; Puisieux F
    J Am Geriatr Soc; 2007 Sep; 55(9):1472-5. PubMed ID: 17767692
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
    Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
    Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
    Nordberg A; Svensson AL
    Drug Saf; 1998 Dec; 19(6):465-80. PubMed ID: 9880090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aricept-induced nightmares in Alzheimer's disease: 2 case reports.
    Ross JS; Shua-Haim JR
    J Am Geriatr Soc; 1998 Jan; 46(1):119-20. PubMed ID: 9434681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
    García-Díaz JD; Fraguas C; Garcimartín C
    Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.